Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Real-world 6 and 12-month Drug Retention, Remission and Response Rates of Secukinumab in 2,017 Psoriatic Arthritis patients in 13 European Countries. Arthritis care & research. 2021.

28/02/2022

Michelsen B, Georgiadis S, Di Giuseppe D, Loft AG, Nissen MJ, Iannone F, et al.

Epub 2021/01/19. doi: 10.1002/acr.24560. PubMed PMID: 33460531.